An injection that eradicated entire tumours in patients with otherwise treatment-resistant cancers in a trial has been praised for its "striking" benefits.

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago ...

An experimental cancer injection has shown promising results in a clinical trial, shrinking or eliminating tumors in some ...

The jab has a three-pronged approach to fighting the cancer. It activates the immune system to attack the tumour, blocks both ...

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy ...

The trial focused on patients with difficult-to-treat or recurrent cancers.

A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells ...